Clinical Trial Detail

NCT ID NCT02503774
Title MEDI9447 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications

Advanced Solid Tumor

Therapies

Durvalumab

Oleclumab

Age Groups: adult

No variant requirements are available.